IFN-CSP Inhibiting Hepatitis B Virus in HepG2.2.15 Cells Involves JAK-STAT Signal Pathway

Frequent and high-dose administration of interferon to patients with viral hepatitis results in various side effects. In our previous study, a novel liver-targeting interferon (IFN-CSP) combining Plasmodium region I peptide with IFNα2b was successfully designed and expressed in the Escherichia coli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xuemei, Wang, Jie, Jin, Xiaobao, Huang, Yanting, Zeng, Wenting, Zhu, Jiayong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378597/
https://www.ncbi.nlm.nih.gov/pubmed/25861653
http://dx.doi.org/10.1155/2015/959684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378597/
https://www.ncbi.nlm.nih.gov/pubmed/25861653
http://dx.doi.org/10.1155/2015/959684

Ejemplares similares